Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00038285 · ClinicalTrials.gov registry record · Phase 2
Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)
A Phase 2 study of Vascular Disease, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00038285 is a Phase 2 study of Vascular Disease that has completed, run by US Department of Veterans Affairs. The trial reports 1 study location across 1 state.
The verdict
NCT00038285, a Phase 2 study of Vascular Disease, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
In the VA, we are achieving progress in decreasing amputation rates through early identification and multidisciplinary treatment of patients at risk for limb loss. Despite these accomplishments, however, clinical outcomes post-amputation, especially for PVD patients, have changed little because of patients' poor cardiovascular condition complicated by the injurious consequences of imposed inactivity begun in the preoperative period and continuing through convalescence. If not aggressively managed throughout all phases of recovery, these problems quickly render patients, already at risk, incapable of the rigors of rehabilitation as well as lead to reamputation, rehabilitation failure, and secondary complications. In our research, we are trying to transform this clinical scenario by applying what has succeeded in cardiac rehabilitation to services provided to amputees. In a series of studies, we are studying how to incorporate secondary CV risk factor modification and aggressive exercise interventions into conventional amputation rehabilitation through a program that we have named Healthy Heart Amputation Rehabilitation Therapy (Healthy H.A.R.T.). Our goal is to better: 1) increase aerobic capacity and promote rehabilitation achievements and quality of life, and 2) prevent postoperative complications and curtail further peripheral vascular deterioration through interventions found successful in cardiac rehabilitation. The basic assumption of this study will be that cardiovascular status and, thus, aerobic capacity is a most critical factor for rehabilitation success.
Conditions Studied
Interventions
- PROCEDURE Amputation Prevention
Study Locations (1)
Texas
- VA Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-04 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00038285
The ClinicalTrials.gov registry entry for NCT00038285 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Amputation Prevention is the first listed.
NCT00038285 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00038285 about?
NCT00038285 is a clinical study titled "Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)". In the VA, we are achieving progress in decreasing amputation rates through early identification and multidisciplinary treatment of patients at risk for limb loss. Despite these accomplishments, however, clinical outcomes post-amputation, especially for PVD patients, have changed little because of p...
What is the current status of trial NCT00038285?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-04. Estimated completion is 2005-03.
What conditions does trial NCT00038285 study?
This clinical trial studies the following conditions: Vascular Disease.
What interventions are being tested in trial NCT00038285?
The interventions under investigation include: Amputation Prevention (PROCEDURE).
Who is sponsoring clinical trial NCT00038285?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00038285 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
RECRUITING
-
Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)
COMPLETED · Phase 1
-
Study of Abnormal Blood Clotting in Children With Stroke
COMPLETED
-
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
COMPLETED · Phase 1
-
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.